カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の注射用発作治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Injectable Seizure Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17957）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17957
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の注射用発作治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

注射用発作治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の注射用発作治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

注射用発作治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・フォスフェニトイン、ミダゾラム、カルバマゼピン、セノバメート、ガバペンチン、フェニトイン、ラモトリギン、トピラマート、レベチラセタム、その他

用途別セグメントは次のように区分されます。
・病院薬局、店舗薬局、オンライン薬局、その他

世界の注射用発作治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer Inc.、GW Pharmaceuticals plc、UCB S.A.、Eisai Co.Ltd.、Sunovion Pharmaceuticals Inc.、H. Lundbeck A/S、GlaxoSmithKline plc、Sandoz Inc.、Omega Laboratories Ltd ERFA Canada 2012 Inc.、Lundbeck Pharmaceuticals Llc、Fresenius Kabi、Mylan Pharmaceuticals、Hoffmann La and

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、注射用発作治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な注射用発作治療薬メーカーの企業概要、2019年～2022年までの注射用発作治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な注射用発作治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別注射用発作治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの注射用発作治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での注射用発作治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および注射用発作治療薬の産業チェーンを掲載しています。
・第13、14、15章では、注射用発作治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 注射用発作治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：フォスフェニトイン、ミダゾラム、カルバマゼピン、セノバメート、ガバペンチン、フェニトイン、ラモトリギン、トピラマート、レベチラセタム、その他
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、店舗薬局、オンライン薬局、その他
- 世界の注射用発作治療薬市場規模・予測
- 世界の注射用発作治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer Inc.、GW Pharmaceuticals plc、UCB S.A.、Eisai Co.Ltd.、Sunovion Pharmaceuticals Inc.、H. Lundbeck A/S、GlaxoSmithKline plc、Sandoz Inc.、Omega Laboratories Ltd ERFA Canada 2012 Inc.、Lundbeck Pharmaceuticals Llc、Fresenius Kabi、Mylan Pharmaceuticals、Hoffmann La and
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：フォスフェニトイン、ミダゾラム、カルバマゼピン、セノバメート、ガバペンチン、フェニトイン、ラモトリギン、トピラマート、レベチラセタム、その他
・用途別分析2017年-2028年：病院薬局、店舗薬局、オンライン薬局、その他
・注射用発作治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・注射用発作治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・注射用発作治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・注射用発作治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・注射用発作治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Injectable Seizure Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Injectable Seizure Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Injectable Seizure Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Fosphenytoin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Injectable Seizure Drugs include Pfizer Inc., GW Pharmaceuticals plc, UCB S.A., Eisai Co.Ltd., and Sunovion Pharmaceuticals Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Injectable Seizure Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fosphenytoin
Midazolam
Carbamazepine
Cenobamate
Gabapentin
Phenytoin
Lamotrigine
Topiramate
Levetiracetam
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
The key market players for global Injectable Seizure Drugs market are listed below:
Pfizer Inc.
GW Pharmaceuticals plc
UCB S.A.
Eisai Co.Ltd.
Sunovion Pharmaceuticals Inc.
H. Lundbeck A/S
GlaxoSmithKline plc
Sandoz Inc.
Omega Laboratories Ltd ERFA Canada 2012 Inc.
Lundbeck Pharmaceuticals Llc
Fresenius Kabi
Mylan Pharmaceuticals
Hoffmann La and
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable Seizure Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Injectable Seizure Drugs, with price, sales, revenue and global market share of Injectable Seizure Drugs from 2019 to 2022.
Chapter 3, the Injectable Seizure Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable Seizure Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Injectable Seizure Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Injectable Seizure Drugs.
Chapter 13, 14, and 15, to describe Injectable Seizure Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Injectable Seizure Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Injectable Seizure Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Fosphenytoin
1.2.3 Midazolam
1.2.4 Carbamazepine
1.2.5 Cenobamate
1.2.6 Gabapentin
1.2.7 Phenytoin
1.2.8 Lamotrigine
1.2.9 Topiramate
1.2.10 Levetiracetam
1.2.11 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Injectable Seizure Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Injectable Seizure Drugs Market Size & Forecast
1.4.1 Global Injectable Seizure Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Injectable Seizure Drugs Sales in Volume (2017-2028)
1.4.3 Global Injectable Seizure Drugs Price (2017-2028)
1.5 Global Injectable Seizure Drugs Production Capacity Analysis
1.5.1 Global Injectable Seizure Drugs Total Production Capacity (2017-2028)
1.5.2 Global Injectable Seizure Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Injectable Seizure Drugs Market Drivers
1.6.2 Injectable Seizure Drugs Market Restraints
1.6.3 Injectable Seizure Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Injectable Seizure Drugs Product and Services
2.1.4 Pfizer Inc. Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GW Pharmaceuticals plc
2.2.1 GW Pharmaceuticals plc Details
2.2.2 GW Pharmaceuticals plc Major Business
2.2.3 GW Pharmaceuticals plc Injectable Seizure Drugs Product and Services
2.2.4 GW Pharmaceuticals plc Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 UCB S.A.
2.3.1 UCB S.A. Details
2.3.2 UCB S.A. Major Business
2.3.3 UCB S.A. Injectable Seizure Drugs Product and Services
2.3.4 UCB S.A. Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Eisai Co.Ltd.
2.4.1 Eisai Co.Ltd. Details
2.4.2 Eisai Co.Ltd. Major Business
2.4.3 Eisai Co.Ltd. Injectable Seizure Drugs Product and Services
2.4.4 Eisai Co.Ltd. Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sunovion Pharmaceuticals Inc.
2.5.1 Sunovion Pharmaceuticals Inc. Details
2.5.2 Sunovion Pharmaceuticals Inc. Major Business
2.5.3 Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Product and Services
2.5.4 Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 H. Lundbeck A/S
2.6.1 H. Lundbeck A/S Details
2.6.2 H. Lundbeck A/S Major Business
2.6.3 H. Lundbeck A/S Injectable Seizure Drugs Product and Services
2.6.4 H. Lundbeck A/S Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GlaxoSmithKline plc
2.7.1 GlaxoSmithKline plc Details
2.7.2 GlaxoSmithKline plc Major Business
2.7.3 GlaxoSmithKline plc Injectable Seizure Drugs Product and Services
2.7.4 GlaxoSmithKline plc Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sandoz Inc.
2.8.1 Sandoz Inc. Details
2.8.2 Sandoz Inc. Major Business
2.8.3 Sandoz Inc. Injectable Seizure Drugs Product and Services
2.8.4 Sandoz Inc. Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Omega Laboratories Ltd ERFA Canada 2012 Inc.
2.9.1 Omega Laboratories Ltd ERFA Canada 2012 Inc. Details
2.9.2 Omega Laboratories Ltd ERFA Canada 2012 Inc. Major Business
2.9.3 Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Product and Services
2.9.4 Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lundbeck Pharmaceuticals Llc
2.10.1 Lundbeck Pharmaceuticals Llc Details
2.10.2 Lundbeck Pharmaceuticals Llc Major Business
2.10.3 Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Product and Services
2.10.4 Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Fresenius Kabi
2.11.1 Fresenius Kabi Details
2.11.2 Fresenius Kabi Major Business
2.11.3 Fresenius Kabi Injectable Seizure Drugs Product and Services
2.11.4 Fresenius Kabi Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Mylan Pharmaceuticals
2.12.1 Mylan Pharmaceuticals Details
2.12.2 Mylan Pharmaceuticals Major Business
2.12.3 Mylan Pharmaceuticals Injectable Seizure Drugs Product and Services
2.12.4 Mylan Pharmaceuticals Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Hoffmann La and
2.13.1 Hoffmann La and Details
2.13.2 Hoffmann La and Major Business
2.13.3 Hoffmann La and Injectable Seizure Drugs Product and Services
2.13.4 Hoffmann La and Injectable Seizure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Injectable Seizure Drugs Breakdown Data by Manufacturer
3.1 Global Injectable Seizure Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Injectable Seizure Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Injectable Seizure Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Injectable Seizure Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Injectable Seizure Drugs Manufacturer Market Share in 2021
3.5 Global Injectable Seizure Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Injectable Seizure Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Injectable Seizure Drugs Market Size by Region
4.1.1 Global Injectable Seizure Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Injectable Seizure Drugs Revenue by Region (2017-2028)
4.2 North America Injectable Seizure Drugs Revenue (2017-2028)
4.3 Europe Injectable Seizure Drugs Revenue (2017-2028)
4.4 Asia-Pacific Injectable Seizure Drugs Revenue (2017-2028)
4.5 South America Injectable Seizure Drugs Revenue (2017-2028)
4.6 Middle East and Africa Injectable Seizure Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Injectable Seizure Drugs Sales in Volume by Type (2017-2028)
5.2 Global Injectable Seizure Drugs Revenue by Type (2017-2028)
5.3 Global Injectable Seizure Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Injectable Seizure Drugs Sales in Volume by Application (2017-2028)
6.2 Global Injectable Seizure Drugs Revenue by Application (2017-2028)
6.3 Global Injectable Seizure Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Injectable Seizure Drugs Sales by Type (2017-2028)
7.2 North America Injectable Seizure Drugs Sales by Application (2017-2028)
7.3 North America Injectable Seizure Drugs Market Size by Country
7.3.1 North America Injectable Seizure Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Injectable Seizure Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Injectable Seizure Drugs Sales by Type (2017-2028)
8.2 Europe Injectable Seizure Drugs Sales by Application (2017-2028)
8.3 Europe Injectable Seizure Drugs Market Size by Country
8.3.1 Europe Injectable Seizure Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Injectable Seizure Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Injectable Seizure Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Injectable Seizure Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Injectable Seizure Drugs Market Size by Region
9.3.1 Asia-Pacific Injectable Seizure Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Injectable Seizure Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Injectable Seizure Drugs Sales by Type (2017-2028)
10.2 South America Injectable Seizure Drugs Sales by Application (2017-2028)
10.3 South America Injectable Seizure Drugs Market Size by Country
10.3.1 South America Injectable Seizure Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Injectable Seizure Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Injectable Seizure Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Injectable Seizure Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Injectable Seizure Drugs Market Size by Country
11.3.1 Middle East & Africa Injectable Seizure Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Injectable Seizure Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Injectable Seizure Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Injectable Seizure Drugs
12.3 Injectable Seizure Drugs Production Process
12.4 Injectable Seizure Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Injectable Seizure Drugs Typical Distributors
13.3 Injectable Seizure Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Injectable Seizure Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Injectable Seizure Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Injectable Seizure Drugs Product and Services
Table 6. Pfizer Inc. Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GW Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 8. GW Pharmaceuticals plc Major Business
Table 9. GW Pharmaceuticals plc Injectable Seizure Drugs Product and Services
Table 10. GW Pharmaceuticals plc Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. UCB S.A. Basic Information, Manufacturing Base and Competitors
Table 12. UCB S.A. Major Business
Table 13. UCB S.A. Injectable Seizure Drugs Product and Services
Table 14. UCB S.A. Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Eisai Co.Ltd. Basic Information, Manufacturing Base and Competitors
Table 16. Eisai Co.Ltd. Major Business
Table 17. Eisai Co.Ltd. Injectable Seizure Drugs Product and Services
Table 18. Eisai Co.Ltd. Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Sunovion Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Sunovion Pharmaceuticals Inc. Major Business
Table 21. Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Product and Services
Table 22. Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. H. Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table 24. H. Lundbeck A/S Major Business
Table 25. H. Lundbeck A/S Injectable Seizure Drugs Product and Services
Table 26. H. Lundbeck A/S Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline plc Major Business
Table 29. GlaxoSmithKline plc Injectable Seizure Drugs Product and Services
Table 30. GlaxoSmithKline plc Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sandoz Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Sandoz Inc. Major Business
Table 33. Sandoz Inc. Injectable Seizure Drugs Product and Services
Table 34. Sandoz Inc. Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Omega Laboratories Ltd ERFA Canada 2012 Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Omega Laboratories Ltd ERFA Canada 2012 Inc. Major Business
Table 37. Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Product and Services
Table 38. Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Lundbeck Pharmaceuticals Llc Basic Information, Manufacturing Base and Competitors
Table 40. Lundbeck Pharmaceuticals Llc Major Business
Table 41. Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Product and Services
Table 42. Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 44. Fresenius Kabi Major Business
Table 45. Fresenius Kabi Injectable Seizure Drugs Product and Services
Table 46. Fresenius Kabi Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Mylan Pharmaceuticals Major Business
Table 49. Mylan Pharmaceuticals Injectable Seizure Drugs Product and Services
Table 50. Mylan Pharmaceuticals Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Hoffmann La and Basic Information, Manufacturing Base and Competitors
Table 52. Hoffmann La and Major Business
Table 53. Hoffmann La and Injectable Seizure Drugs Product and Services
Table 54. Hoffmann La and Injectable Seizure Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Injectable Seizure Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Injectable Seizure Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Injectable Seizure Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Injectable Seizure Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Injectable Seizure Drugs Production Site of Key Manufacturer
Table 60. Injectable Seizure Drugs New Entrant and Capacity Expansion Plans
Table 61. Injectable Seizure Drugs Mergers & Acquisitions in the Past Five Years
Table 62. Global Injectable Seizure Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Global Injectable Seizure Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Global Injectable Seizure Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Injectable Seizure Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Injectable Seizure Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Global Injectable Seizure Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Global Injectable Seizure Drugs Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Injectable Seizure Drugs Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Injectable Seizure Drugs Price by Type (2017-2022) & (US$/Unit)
Table 71. Global Injectable Seizure Drugs Price by Type (2023-2028) & (US$/Unit)
Table 72. Global Injectable Seizure Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Global Injectable Seizure Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Global Injectable Seizure Drugs Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Injectable Seizure Drugs Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Injectable Seizure Drugs Price by Application (2017-2022) & (US$/Unit)
Table 77. Global Injectable Seizure Drugs Price by Application (2023-2028) & (US$/Unit)
Table 78. North America Injectable Seizure Drugs Sales by Country (2017-2022) & (K Units)
Table 79. North America Injectable Seizure Drugs Sales by Country (2023-2028) & (K Units)
Table 80. North America Injectable Seizure Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Injectable Seizure Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Injectable Seizure Drugs Sales by Type (2017-2022) & (K Units)
Table 83. North America Injectable Seizure Drugs Sales by Type (2023-2028) & (K Units)
Table 84. North America Injectable Seizure Drugs Sales by Application (2017-2022) & (K Units)
Table 85. North America Injectable Seizure Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Europe Injectable Seizure Drugs Sales by Country (2017-2022) & (K Units)
Table 87. Europe Injectable Seizure Drugs Sales by Country (2023-2028) & (K Units)
Table 88. Europe Injectable Seizure Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Injectable Seizure Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Injectable Seizure Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Europe Injectable Seizure Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Europe Injectable Seizure Drugs Sales by Application (2017-2022) & (K Units)
Table 93. Europe Injectable Seizure Drugs Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Injectable Seizure Drugs Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Injectable Seizure Drugs Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Injectable Seizure Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Injectable Seizure Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Injectable Seizure Drugs Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Injectable Seizure Drugs Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Injectable Seizure Drugs Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Injectable Seizure Drugs Sales by Application (2023-2028) & (K Units)
Table 102. South America Injectable Seizure Drugs Sales by Country (2017-2022) & (K Units)
Table 103. South America Injectable Seizure Drugs Sales by Country (2023-2028) & (K Units)
Table 104. South America Injectable Seizure Drugs Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Injectable Seizure Drugs Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Injectable Seizure Drugs Sales by Type (2017-2022) & (K Units)
Table 107. South America Injectable Seizure Drugs Sales by Type (2023-2028) & (K Units)
Table 108. South America Injectable Seizure Drugs Sales by Application (2017-2022) & (K Units)
Table 109. South America Injectable Seizure Drugs Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Injectable Seizure Drugs Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Injectable Seizure Drugs Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Injectable Seizure Drugs Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Injectable Seizure Drugs Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Injectable Seizure Drugs Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Injectable Seizure Drugs Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Injectable Seizure Drugs Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Injectable Seizure Drugs Sales by Application (2023-2028) & (K Units)
Table 118. Injectable Seizure Drugs Raw Material
Table 119. Key Manufacturers of Injectable Seizure Drugs Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Injectable Seizure Drugs Typical Distributors
Table 123. Injectable Seizure Drugs Typical Customers
List of Figures
Figure 1. Injectable Seizure Drugs Picture
Figure 2. Global Injectable Seizure Drugs Revenue Market Share by Type in 2021
Figure 3. Fosphenytoin
Figure 4. Midazolam
Figure 5. Carbamazepine
Figure 6. Cenobamate
Figure 7. Gabapentin
Figure 8. Phenytoin
Figure 9. Lamotrigine
Figure 10. Topiramate
Figure 11. Levetiracetam
Figure 12. Others
Figure 13. Global Injectable Seizure Drugs Revenue Market Share by Application in 2021
Figure 14. Hospital Pharmacies
Figure 15. Retail Pharmacies
Figure 16. Online Pharmacies
Figure 17. Others
Figure 18. Global Injectable Seizure Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 19. Global Injectable Seizure Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 20. Global Injectable Seizure Drugs Sales (2017-2028) & (K Units)
Figure 21. Global Injectable Seizure Drugs Price (2017-2028) & (US$/Unit)
Figure 22. Global Injectable Seizure Drugs Production Capacity (2017-2028) & (K Units)
Figure 23. Global Injectable Seizure Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 24. Injectable Seizure Drugs Market Drivers
Figure 25. Injectable Seizure Drugs Market Restraints
Figure 26. Injectable Seizure Drugs Market Trends
Figure 27. Global Injectable Seizure Drugs Sales Market Share by Manufacturer in 2021
Figure 28. Global Injectable Seizure Drugs Revenue Market Share by Manufacturer in 2021
Figure 29. Injectable Seizure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 30. Top 3 Injectable Seizure Drugs Manufacturer (Revenue) Market Share in 2021
Figure 31. Top 6 Injectable Seizure Drugs Manufacturer (Revenue) Market Share in 2021
Figure 32. Global Injectable Seizure Drugs Sales Market Share by Region (2017-2028)
Figure 33. Global Injectable Seizure Drugs Revenue Market Share by Region (2017-2028)
Figure 34. North America Injectable Seizure Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Europe Injectable Seizure Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Asia-Pacific Injectable Seizure Drugs Revenue (2017-2028) & (USD Million)
Figure 37. South America Injectable Seizure Drugs Revenue (2017-2028) & (USD Million)
Figure 38. Middle East & Africa Injectable Seizure Drugs Revenue (2017-2028) & (USD Million)
Figure 39. Global Injectable Seizure Drugs Sales Market Share by Type (2017-2028)
Figure 40. Global Injectable Seizure Drugs Revenue Market Share by Type (2017-2028)
Figure 41. Global Injectable Seizure Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 42. Global Injectable Seizure Drugs Sales Market Share by Application (2017-2028)
Figure 43. Global Injectable Seizure Drugs Revenue Market Share by Application (2017-2028)
Figure 44. Global Injectable Seizure Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 45. North America Injectable Seizure Drugs Sales Market Share by Type (2017-2028)
Figure 46. North America Injectable Seizure Drugs Sales Market Share by Application (2017-2028)
Figure 47. North America Injectable Seizure Drugs Sales Market Share by Country (2017-2028)
Figure 48. North America Injectable Seizure Drugs Revenue Market Share by Country (2017-2028)
Figure 49. United States Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Injectable Seizure Drugs Sales Market Share by Type (2017-2028)
Figure 53. Europe Injectable Seizure Drugs Sales Market Share by Application (2017-2028)
Figure 54. Europe Injectable Seizure Drugs Sales Market Share by Country (2017-2028)
Figure 55. Europe Injectable Seizure Drugs Revenue Market Share by Country (2017-2028)
Figure 56. Germany Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Injectable Seizure Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Injectable Seizure Drugs Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Injectable Seizure Drugs Sales Market Share by Region (2017-2028)
Figure 64. Asia-Pacific Injectable Seizure Drugs Revenue Market Share by Region (2017-2028)
Figure 65. China Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Korea Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Injectable Seizure Drugs Sales Market Share by Type (2017-2028)
Figure 72. South America Injectable Seizure Drugs Sales Market Share by Application (2017-2028)
Figure 73. South America Injectable Seizure Drugs Sales Market Share by Country (2017-2028)
Figure 74. South America Injectable Seizure Drugs Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East & Africa Injectable Seizure Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East & Africa Injectable Seizure Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East & Africa Injectable Seizure Drugs Sales Market Share by Region (2017-2028)
Figure 80. Middle East & Africa Injectable Seizure Drugs Revenue Market Share by Region (2017-2028)
Figure 81. Turkey Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Egypt Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. South Africa Injectable Seizure Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Manufacturing Cost Structure Analysis of Injectable Seizure Drugs in 2021
Figure 86. Manufacturing Process Analysis of Injectable Seizure Drugs
Figure 87. Injectable Seizure Drugs Industrial Chain
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
Figure 89. Methodology
Figure 90. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注射可能型発作治療薬の世界市場2023年：ホスフェニトイン、ミダゾラム、カルバマゼピン、セノバメート、ガバペンチン、フェニトイン、ラモトリジン、トピラメート、レベチラセタム、その他
  • 世界の注射用糖尿病治療薬市場2022年：市場規模予測（～2028年）
  • 世界の2型糖尿病用注射剤市場2022年：市場規模予測（～2028年）
  • 世界の腫瘍用ジェネリック注射剤市場2022年：市場規模予測（～2028年）
  • 世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17957 )"世界の注射用発作治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Injectable Seizure Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。